Monoclonal antibody therapy for B cell non-Hodgkin’s lymphomas: emerging concepts of a tumour-targeted strategy
- 1 April 1999
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (4) , 549-557
- https://doi.org/10.1016/s0959-8049(98)00420-1
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Intensely Cytotoxic Anthracycline Prodrugs: GlucuronidesJournal of Medicinal Chemistry, 1997
- Radioimmunotherapy strategies for non-Hodgkin's lymphomasAnnals of Oncology, 1997
- Clinical significance of IgG Fc receptors and FcγR-directed immunotherapiesImmunology Today, 1997
- Interleukin-2 fusion protein: An investigational therapy for interleukin-2 receptor expressing malignanciesEuropean Journal Of Cancer, 1997
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Non-Hodgkin's lymphomas—current status of therapy and future perspectivesEuropean Journal Of Cancer, 1995
- Recombinant Immunotoxins: From Basic Research to Cancer TherapyMethods, 1995
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Bacterial expression of immunoglobulin fragmentsCurrent Opinion in Immunology, 1993
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986